SEC Form 4 · accession 0001104659-15-079932

Voyager Therapeutics, Inc. · VYGR

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner

Director

Period of report

Nov 16, 2015

Accepted (ET)

Nov 18, 2015 · 4:04 pm EST

Rule 10b5-1 plan

unknown — predates the checkbox

Issuer CIK

0001640266

Table I — non-derivative securities

Security	Date	Code	Shares	Price	A/D	Owned after	D/I	Nature of ownership
Common Stock^F1,F2	Nov 16, 2015	C	10,588,235	—	A	11,061,176	I	See Footnote

Security	Conv. / exercise price	Date	Code	Shares	A/D	Exercisable	Expires	Underlying	Underlying shares	Owned after	D/I
Series A Preferred Stock^F2,F1	—	Nov 16, 2015	C	45,000,000	D	—	—	Common Stock	10,588,235	0	I

F1The Series A Preferred Stock converted into Common Stock on a 1-for-4.25 basis automatically upon the closing of the Issuer's initial public offering on November 16, 2015 and had no expiration date.
F2The shares are directly held by Third Rock Ventures III, L.P. ("TRV III"). The general partner of TRV III is Third Rock Ventures GP III, L.P. ("TRV GP III LP"). The general partner of TRV GP III LP is TRV GP III, LLC ("TRV GP III LLC"). The individual managers of TRV GP III LLC are Mark Levin ("Levin"), Kevin Starr ("Starr") and Dr. Robert Tepper ("Tepper") and, as such, each of TRV GP III LP and TRV GP III LLC, Levin, Starr and Tepper exercises shared voting and investment power over the shares held of record by TRV III. The Reporting Person disclaims beneficial ownership of the shares except to the extent of his pecuniary interest therein, if any.